Il affrontera la concurrence d'acteurs disposant d'une assise financière et commerciale importante, en particulier les groupes Merck, Rhône Poulenc Rorer, Hoechst Marion Roussel, Glaxo Wellcome, Novartis, Bristol Myers Squibb, Johnson Johnson et Pfizer.
It will face competition from companies which have an important financial and commercial basis, in particular Merck, Rhône Poulenc Rorer, Hoechst Marion Roussel, Glaxo Wellcome, Novartis, Bristol Myers Squibb, Johnson Johnson and Pfizer.